127 related articles for article (PubMed ID: 16806647)
41. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.
Elfström KM; Smelov V; Johansson AL; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
BMJ; 2014 Jan; 348():g130. PubMed ID: 24435414
[TBL] [Abstract][Full Text] [Related]
42. Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease: A Case-controlled Cohort Study.
Goetgebuer RL; Kreijne JE; Aitken CA; Dijkstra G; Hoentjen F; de Boer NK; Oldenburg B; van der Meulen AE; Ponsioen CIJ; Pierik MJ; van Kemenade FJ; de Kok IMCM; Siebers AG; Manniën J; van der Woude CJ; de Vries AC
J Crohns Colitis; 2021 Sep; 15(9):1464-1473. PubMed ID: 33609353
[TBL] [Abstract][Full Text] [Related]
43. Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results.
Cohen D; Austin RM; Gilbert C; Freij R; Zhao C
Am J Clin Pathol; 2012 Oct; 138(4):517-23. PubMed ID: 23010706
[TBL] [Abstract][Full Text] [Related]
44. HPV screening performance indicators in women who previously tested HPV-negative: The second round of Vallecamonica screening programme, Northern Italy.
Pasquale L; Rossi PG; Carozzi F; Domenighini S; Ruggeri C; Cecconami L; Morana C; Chiaramonte M; Chiudinelli D; Piccolomini M; Marchione R; Confortini M
J Med Screen; 2020 Dec; 27(4):207-214. PubMed ID: 32102618
[TBL] [Abstract][Full Text] [Related]
45. [Follow-up and treatment of cervical intraepithelial neoplasia (current trends)].
Sopena B
Ann Pathol; 1996 Nov; 16(5):356-63. PubMed ID: 9004723
[No Abstract] [Full Text] [Related]
46. Cervical cytologic abnormalities of cervical intraepithelial neoplasia 1 treated with cryotherapy and expectant management during the first year follow-up period.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2009; 10(4):665-8. PubMed ID: 19827891
[TBL] [Abstract][Full Text] [Related]
47. Conservative management of biopsy confirmed high-grade squamous intraepithelial lesions.
Hederlingova J; Redman CW; Zahumensky J
Bratisl Lek Listy; 2017; 118(12):732-735. PubMed ID: 29322804
[TBL] [Abstract][Full Text] [Related]
48. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
[TBL] [Abstract][Full Text] [Related]
49. Completeness of excision and follow up cytology in patients treated with loop excision biopsy.
Zaitoun AM; McKee G; Coppen MJ; Thomas SM; Wilson PO
J Clin Pathol; 2000 Mar; 53(3):191-6. PubMed ID: 10823137
[TBL] [Abstract][Full Text] [Related]
50. Predictors of recurrence in high-grade cervical lesions and a plan of management.
Leguevaque P; Motton S; Decharme A; Soulé-Tholy M; Escourrou G; Hoff J
Eur J Surg Oncol; 2010 Nov; 36(11):1073-9. PubMed ID: 20870375
[TBL] [Abstract][Full Text] [Related]
51. The use of cold coagulation for the treatment of cervical intraepithelial neoplasia.
Wyse A; Seah WA; O'Neill J; Byrne P
Ir Med J; 2017 May; 110(5):565. PubMed ID: 28737306
[TBL] [Abstract][Full Text] [Related]
52. Randomized study comparing two techniques of conization: cold knife versus loop excision.
Giacalone PL; Laffargue F; Aligier N; Roger P; Combecal J; Daures JP
Gynecol Oncol; 1999 Dec; 75(3):356-60. PubMed ID: 10600289
[TBL] [Abstract][Full Text] [Related]
53. Performance indicators of organized cervical screening in Romagna (Italy).
Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
[TBL] [Abstract][Full Text] [Related]
54. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
55. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
Skorstengaard M; Lynge E; Suhr J; Napolitano G
BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
[TBL] [Abstract][Full Text] [Related]
56. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
57. Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya.
Khozaim K; Orang'o E; Christoffersen-Deb A; Itsura P; Oguda J; Muliro H; Ndiema J; Mwangi G; Strother M; Cu-Uvin S; Rosen B; Washington S
Int J Gynaecol Obstet; 2014 Jan; 124(1):12-8. PubMed ID: 24140218
[TBL] [Abstract][Full Text] [Related]
58. Conservative management of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women.
Vlahos G; Rodolakis A; Diakomanolis E; Stefanidis K; Haidopoulos D; Abela K; Georgountzos V; Michalas S
Gynecol Obstet Invest; 2002; 54(2):78-81. PubMed ID: 12566748
[TBL] [Abstract][Full Text] [Related]
59. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
TOMBOLA Group
BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
[TBL] [Abstract][Full Text] [Related]
60. Management options for cervical intraepithelial neoplasia.
Petry KU
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):641-51. PubMed ID: 21723198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
